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Abstract 
Seven new indole-fused oleanolic acid derivatives were synthesized from oleanolic acid for their 
ability to inhibit cell proliferation in NRP.152 cells. 
 






Triterpenoids are a diverse and ubiquitous group of C30 pentacyclic compounds1 that are derived 
biosynthetically from squalene cyclization.2 Many triterpenoids display interesting biological and 
pharmacological profiles,3 which include the selective inhibition of inducible nitric oxide 
synthase (iNOS)4-7 and cyclooxygenase-2 (COX-2),5,6,8 modulation of collagen synthesis,9-11 
inhibition of tumorigenesis,12,13 and the ability to affect cell proliferation.14,15 
As part of our efforts to synthesize and screen for biological activity novel derivatives of 
oleanolic (1) and ursolic acid (2),5,6,16-20 we reported the ability of some 70 synthetic 
triterpenoids to affect cell proliferation in epithelial nonmalignant NRP.152 and malignant 
NRP.154 prostate cells.21 These NRP.152 prostate cells demonstrate sensitivity to retinoids and 
1α,25-dihydroxyvitamin D3 and may be used for analysis of normal prostate growth and 
prostatic carcinogenesis.22,23 Compounds that inhibit nonmalignant prostate cell proliferation 
mediated by the induction of TGF-β demonstrate potential as chemopreventive agents for 
prostate (and breast) cancer.24 
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Results and Discussion 
 
In the present paper we describe the synthesis of seven new indole-fused oleanolic acid 
derivatives, 3–9, for evaluation in the NRP.252 cell assay. Fused heterocyclic derivatives of 
steroids and alkaloids are well documented,25 and biologically active indole-fused examples are 
of particular interest.26 Furthermore, several indole-fused steroids have been synthesized for 
electron-transfer studies.27-30 In contrast, only one research group has described the synthesis of 
indole-fused triterpenoids.31,32 Interestingly, a number of indole-fused diterpenes, such as the 
penitrems, are Penicillium fungal metabolites.33 Our syntheses of the target compounds 3–9 






















































As we have previously described,16 sequential diazomethane treatment and Jones oxidation 
of oleanolic acid (1) furnished keto ester 10 in 94% yield (Scheme 1). Fischer indolization of 10 
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with phenylhydrazine in acetic acid gave the known32 fused indole ester 11 in 90% yield. 
Cleavage of this hindered methyl ester with lithium iodide in DMF36 afforded 3 in 54% yield. 
The corresponding C-3 ketone obtained from 1 also underwent Fischer indolization to give 3 in 
61% yield, but a persistent yellow contaminant could not be removed from 3 by either 




























Due to the susceptibility of the indole ring in 3 to side reactions, particularly oxidation, 
modifications to the C-ring were performed prior to indolization. Thus, as shown in Scheme 2, 
and as we have previously described,20 the synthesis of 3,12-diketone 12 was accomplished via 
an acid mediated epoxide rearrangement that occurred upon treatment of 10 with m-CPBA. 
Fischer indolization of 12 (74%) followed by ester cleavage (59%) gave the desired fused indole 
4. The highly hindered C-12 ketone in 12 remains unaffected under these Fischer indole reaction 
conditions.37 Likewise, as we have reported,20 allylic oxidation of 10 gave the known C-12,13 
enone 13 (45% yield), which, upon Fischer indolization (79% yield) and ester cleavage (55% 
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The indole ring substituted analogs 6–9 were synthesized by employing the appropriate 
substituted phenylhydrazine in the Fischer indolization (Scheme 3). Thus, treatment of 10 with 
2-chlorophenylhydrazine38 gave indole 14 that could be converted to indole 6 by ester cleavage. 
This indolization reaction was accompanied by 31% of uncyclized hydrazone. A sequence 
starting with 3-fluorophenylhydrazine yielded a mixture of indoles 15 and 16, which were 
separated by sequential column and preparative silica gel chromatography in a 2:1 ratio, 




















































c 43% c 80%
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Finally, the 5-methoxyindole derivative 9 was synthesized directly from 3-keto acid 17 by 
Fischer indolization in 62% yield. The known keto acid 17 was prepared from oleanolic acid (1) 
by Jones oxidation (95% yield) as previously described.16 Interestingly, the corresponding 
methyl ester analog that was prepared by indolization of 10 decomposed under the lithium iodide 
ester cleavage conditions. 
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Unfortunately, attempts to effect indolization of C-12 ring C ketone derivatives were 
unsuccessful, presumably due to the hindered nature of this position. For example, we could not 
prepare the phenylhydrazone of ketones 18 and 19, or effect indolization of ketones 19 and 20 














18 19 20  
 
Oleanolic acid (1), indoles 3-9, and 10, 12, and 13 were screened in vitro for their ability to 
inhibit proliferation of premalignant, non-tumorigenic prostate cells. Of the compounds prepared 
in the present study, only 4 and 5 showed some activity (IC50 <5 µM). All of the others were 
essentially inactive in this assay (>5 µM). For comparison, TGF-β has IC50 = 0.000014 µΜ.40 
Therefore, in view of the disappointing activity in this assay of this series of fused-indole 






General Procedures. Flash column chromatography was done with Select Scientific silica gel 
(230–400 mesh). 1H (300 MHz) and 13C (75 MHz) NMR spectra were recorded on a Varian XL-
300 spectrometer in CDCl3 solvent; chemical shifts are reported with reference to the δ 7.27 
signal of CHCl3 (1H NMR) and δ 77.23 signal of CDCl3 (13C NMR) as an internal standard.  
 
General procedure for Fischer indolization 
A mixture of ketone 10 (89.3 mg, 0.191 mmol), phenylhydrazine (0.02 mL, d = 1.1, 1.05 eq), 
and glacial acetic acid (2 mL) was heated at reflux under N2 for 30 min. During this period the 
color changed from colorless to bright yellow. The reaction mixture was pipetted into distilled 
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water (50 mL) and extracted with ether (4 x 20 mL). The combined ether extracts were washed 
with 5% aqueous NaOH (2 x 20 mL) and brine (2 x 20 mL), dried (Na2SO4), and concentrated in 
vacuo to afford a yellow solid. Flash chromatography over silica gel and elution with hexane-
ethyl acetate afforded indole 11 (92.4 mg, 90%) as an amorphous pale yellow solid. The 
synthesis of indole 9 from ketone 17 was worked up by simply pouring into water, extracting 
with ethyl acetate, and processing in the usual way to give an amorphous product after flash 
chromatography. Indoles 9, 11, and 14–16 were all amorphous solids and were directly 
converted into the corresponding acids as described below. 
 
General procedure for ester cleavage 
A mixture of indole ester (0.09 mmol) and lithium iodide (0.45 mmol) in DMF (1.5 mL) under 
N2 was heated at reflux for 15 h. The mixture was allowed to cool, treated with water (20 mL) 
and 10% aqueous hydrochloric acid (5 mL), and extracted with dichloromethane (3 x 20 mL). 
The organic layer was washed with water, dried (MgSO4), and concentrated in vacuo to afford 
the crude acid. Purification was effected by preparative TLC (hexane/ethyl acetate, 4:1) to give 
3–8 as amorphous solids, for which melting points could not be obtained. The amounts of 
compounds, which were needed for biological screening, were insufficient for crystallization. 
Spectra data of 3–9 are tabulated in Tables 1–3. 
 
Table 1. High-Resolution Mass Spectral Data of 3–6, 9 [m/z] 
Compound M+, Calculated M+, Observed 
3 C36H49NO2 527.3763 527.3751 
4 C36H49NO3 543.3712 543.3672 
5 C36H47NO3 541.3556 541.3582 
6 C36H48NO2Cl 561.3374 561.3385 
9 C37H51NO3 557.3869 557.3884 
 
Table 2. 1H NMR data of 3–9: δ [ppm]; coupling constants J [Hz] 
 Me H-1 H-12 H-18 NH Aromatic Other 
3 0.85, 0.90, 2.75; 15.3 5.38 2.87; 9.9 7.70 7.41; 6.9 - 
 0.94 (2), 1.15, 2.18; 15.9 1.15   7.28; 7.5  
 1.17, 1.27     7.07 (2)  
4 0.87, 0.92 2.69; 14.7  2.80 7.75 7.40; 7.5 2.49; 5.1, 17.1 
 1.00 (2), 1.07, 2.14; 14.7    7.27; 7.2 2.33; 13,1 6.5 (H-11) 
 1.15, 1.28     7.08; (2) 2.75; 4.2 (H-13) 
5 0.94, 0.95, 3.96; 15.6 5.72 3.01 7.72 7.49; 7.2 2.62 (H-9) 
 0.99, 1.13, 2.25; 15.6    7.27; 7.2  
 1.15, 1.26, 1.39     7.07 (2)  
6 0.84, 0.90, 2.73; 15.0 5.37 2.86; 9.9 7.84 7.30; 7.5  
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Table 2. Continued 
 0.93 (2), 1.17, 2.18; 15.0    7.09; 1.2, 7.8  
 1.19, 1.30     6.97; 7.8, 7.8  
7 0.84, 0.90, 2.71; 14.7 5.37 2.87; 13.5 7.71 7.29; 5.4, 8.7  
 0.94, 0.96, 2.16; 14.7    6.96; 2.4, 9.9  
 1.14, 1.17, 1.26     6.80; 2.4, 9.0, 
9.9 
 
8 0.84, 0.90, 2.98; 15.6 5.37 2.86; 13.5 7.76 7.04; 8.1  
 0.94, 0.96, 2.35; 15.6    6.98 5.1, 7.8  
 1.15, 1.16, 1.26     6.67; 7.5, 10.8  
9 0.84, 0.90, 2.70; 14.7 5.37 2.86; 12.6 7.59 7.16; 8.4 3.83 (OMe) 
 0.94 (2), 1.14, 2.16; 15.3    6.87; 2.4  
 1.17, 1.25     6.75; 8.7, 2.4  
 
Table 3. 13C NMR Data of 3–9: δ [ppm] 
 CO2H Ketone C=C Aromatic 
3 184.5  145.6 141.0, 136.3, 128.4, 
   123.1 121.2, 119.1, 118.2, 110.5, 107.1 
4 184.7 211.8  140.7, 136.3, 128.2, 121.4, 
    119.3, 118.2, 110.6, 106.5 
5 178.4 199.6 169.5 141.3, 137.6, 129.0, 120.9, 
6 184.4  143.6 141.9, 133.4, 129.9, 120.6, 
7 184.6  143.6 161.3, 158.1, 143.6, 141.3, 
   125.0 136.3, 136.1, 123.0, 118.7, 
    107.3, 107.0, 97.0 
8 184.5  143.4 155.6, 140.8, 139.0, 138.9, 
   123.2 121.4, 116.9, 111.5, 106.6, 
    105.7, 104.6 
9 184.3  143.6 154.0, 142.1, 131.4, 128.8, 
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